Effects of borohydride-treated oligomycins on processes of energy transduction in mitochondria.
Sodium borohydride in ethanol solution under mild conditions brings about the stepwise reduction of the 7-keto and the 11-keto groups of rutamycin and the oligomycins to the corresponding hydroxyl groups without further alterations of the macrocyclic lactone structure or other features of the molecule. The reduced compounds, as well as the parent antibiotics, inhibit the ADP-dependent (state 3) respiration, and the Pi formation and proton extrusion that are linked to ATP hydrolysis, but have no effect on other respiration-linked activities in intact rat liver mitochondria. Analogous inhibitory effects of borohydride-treated antibiotics are also observed in rat-liver submitochondrial particles. The reduced compounds are less potent inhibitors than the parent antibiotics. The reduced compounds are more efficient as inhibitors of Pi formation stimulated by conventional uncouplers (e.g. 2,4-dinitrophenol), than of Pi formation stimulated by certain amine-fluorescamine modifiers (e.g.) the benzylamine-fluorescamine compound. In contrast, the parent antibiotics are unable to discriminate between uncoupler-stimulated and modifier-stimulated Pi formation. It is suggested that rutamycin and the oligomycins bind to H+-ATPase as a result of hydrogen bonding to, at least, the 7-keto and/or the 11-keto groups of the antibiotics. When these keto groups are reduced to hydroxyl groups the hydrogen-bonding is less efficient due to the pronounced directional characteristic of hydrogen-bonding to keto groups.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D001596:Benzylamines / Q000494:pharmacology; D001894:Borohydrides / Q000494:pharmacology*; D005450:Fluorescamine / Q000494:pharmacology; D066298:In Vitro Techniques; D008930:Mitochondria, Liver / Q000201:enzymology*; D009840:Oligomycins / Q000037:antagonists & inhibitors*; D010084:Oxidation-Reduction / Q000187:drug effects; D051381:Rats; D012427:Rutamycin / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013347:Subcellular Fractions / Q000032:analysis
D001596:Benzylamines; D001894:Borohydrides; D009840:Oligomycins; D005450:Fluorescamine; D012427:Rutamycin; C025364:sodium borohydride; D000251:Adenosine Triphosphatases